Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study.

Grebely J, Alavi M, Micallef M, Dunlop AJ, Balcomb AC, Phung N, Weltman MD, Day CA, Treloar C, Bath N, Haber PS, Dore GJ; ETHOS Study Group.

Addiction. 2016 Feb;111(2):311-9. doi: 10.1111/add.13197. Epub 2015 Nov 25.

PMID:
26451534
2.

Assessment and delivery of treatment for hepatitis C virus infection in an opioid substitution treatment clinic with integrated peer-based support in Newcastle, Australia.

Keats J, Micallef M, Grebely J, Hazelwood S, Everingham H, Shrestha N, Jones T, Bath N, Treloar C, Dore GJ, Dunlop A; ETHOS Study Group.

Int J Drug Policy. 2015 Oct;26(10):999-1006. doi: 10.1016/j.drugpo.2015.07.006. Epub 2015 Jul 17.

PMID:
26275578
3.

Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study.

Marshall AD, Micallef M, Erratt A, Telenta J, Treloar C, Everingham H, Jones SC, Bath N, How-Chow D, Byrne J, Harvey P, Dunlop A, Jauncey M, Read P, Collie T, Dore GJ, Grebely J.

Int J Drug Policy. 2015 Oct;26(10):984-91. doi: 10.1016/j.drugpo.2015.07.002. Epub 2015 Jul 16.

PMID:
26256938
4.

The effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use: The ETHOS study.

Fortier E, Alavi M, Micallef M, Dunlop AJ, Balcomb AC, Day CA, Treloar C, Bath N, Haber PS, Dore GJ, Bruneau J, Grebely J; ETHOS Study Group.

Int J Drug Policy. 2015 Nov;26(11):1094-102. doi: 10.1016/j.drugpo.2015.06.001. Epub 2015 Jun 11.

PMID:
26145482
5.

Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the ETHOS study.

Alavi M, Micallef M, Fortier E, Dunlop AJ, Balcomb AC, Day CA, Treloar C, Bath N, Haber PS, Dore GJ, Grebely J; ETHOS Study Group.

J Viral Hepat. 2015 Nov;22(11):914-25. doi: 10.1111/jvh.12415. Epub 2015 May 21.

PMID:
25996567
6.

Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, Australia.

Treloar C, Rance J, Bath N, Everingham H, Micallef M, Day C, Hazelwood S, Grebely J, Dore GJ.

Int J Drug Policy. 2015 Oct;26(10):992-8. doi: 10.1016/j.drugpo.2015.01.005. Epub 2015 Jan 24.

PMID:
25697089
7.

How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting.

Treloar C, Rance J; ETHOS Study Group.

Int J Drug Policy. 2014 Sep;25(5):865-70. doi: 10.1016/j.drugpo.2014.01.011. Epub 2014 Jan 26.

PMID:
24559604
8.

Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study.

Treloar C, Rance J, Dore GJ, Grebely J; ETHOS Study Group.

J Viral Hepat. 2014 Aug;21(8):560-7. doi: 10.1111/jvh.12183. Epub 2013 Dec 3.

PMID:
24299222
9.

Investigating the balance of reporting maternal and infant outcomes in pregnancy and childbirth Cochrane reviews.

Starrick E, Bath N, Haas DM.

Am J Perinatol. 2014 Sep;31(8):689-94. doi: 10.1055/s-0033-1357266. Epub 2013 Oct 9.

PMID:
24108666
10.

Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection.

Crawford S, Bath N.

Clin Infect Dis. 2013 Aug;57 Suppl 2:S75-9. doi: 10.1093/cid/cit297. Review.

11.

Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study.

Alavi M, Grebely J, Micallef M, Dunlop AJ, Balcomb AC, Day CA, Treloar C, Bath N, Haber PS, Dore GJ; Enhancing Treatment for Hepatitis C in Opioid Substitution Settings (ETHOS) Study Group.

Clin Infect Dis. 2013 Aug;57 Suppl 2:S62-9. doi: 10.1093/cid/cit305.

12.

Injecting drug use among gay and bisexual men in Sydney: prevalence and associations with sexual risk practices and HIV and hepatitis C infection.

Lea T, Mao L, Bath N, Prestage G, Zablotska I, de Wit J, Holt M.

AIDS Behav. 2013 May;17(4):1344-51. doi: 10.1007/s10461-013-0409-0.

PMID:
23321949
13.

Poor uptake of community based sexually transmissible infection testing at an inner city needle and syringe program.

Martin L, Crawford S, Knight V, Bath N, McNulty A.

Sex Health. 2013 May;10(2):183-4. doi: 10.1071/SH12078.

PMID:
23158773
14.

Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment.

Madden A, Lea T, Bath N, Winstock AR.

Drug Alcohol Rev. 2008 Nov;27(6):671-8. doi: 10.1080/09595230801935706.

PMID:
19378450
15.

Consumers' and providers' perspectives about consumer participation in drug treatment services: is there support to do more? What are the obstacles?

Bryant J, Saxton M, Madden A, Bath N, Robinson S.

Drug Alcohol Rev. 2008 Mar;27(2):138-44. doi: 10.1080/09595230701829405.

PMID:
18264873
16.

Consumer participation in the planning and delivery of drug treatment services: the current arrangements.

Bryant J, Saxton M, Madden A, Bath N, Robinson S.

Drug Alcohol Rev. 2008 Mar;27(2):130-7. doi: 10.1080/09595230701829397.

PMID:
18264872
17.

Comparison of unsafe drinking between a rural and metropolitan area.

Peach HG, Bath NE, Farish SJ.

Drug Alcohol Rev. 1998 Mar;17(1):117-20.

PMID:
16203475
18.

Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001.

Law MG, Dore GJ, Bath N, Thompson S, Crofts N, Dolan K, Giles W, Gow P, Kaldor J, Loveday S, Powell E, Spencer J, Wodak A.

Int J Epidemiol. 2003 Oct;32(5):717-24.

19.
20.

Comparison of a general practice and hospital placement on medical students' insights into rural practice.

Peach H, Bath N.

Med Teach. 2001 Jan;23(1):102-103. No abstract available.

PMID:
11260755
Items per page

Supplemental Content

Loading ...
Write to the Help Desk